Compared to placebo, high-dose recombinant human erythropoietin within 2 days of life does not improve neurodevelopmental outcomes for preterm infants.

Hospitals located in the most disadvantaged communities have a lower likelihood of adopting any stroke certification.

The number and size of seizures of fentanyl are increasing in the United States, with most seizures occurring in the West.

A third dose of COVID-19 vaccine is beneficial among older Medicare beneficiaries, regardless of prior medically attended COVID-19 diagnoses.

Patients, especially women, with PTSD in low-income areas were more likely to rapidly reduce or discontinue opioids than those in high-income areas.

Compared to acute, continuation and maintenance electroconvulsive therapy significantly reduced risk of hospitalization and health care costs.

HealthDay News — Black individuals are diagnosed with Huntington disease (HD) at least one year later than White individuals, according to a study published online June 21 in Neurology: Clinical ...

Mean quantity of opioids dispensed in initial prescription was 227 MME; 3.0 percent of youths refilled a prescription 91 to 180 days after surgery. HealthDay News — Overall, 16.2 percent of ...

Transcranial direct current stimulation combined with transcranial magnetic stimulation provides safe and more effective major depressive disorder treatment.

Reductions in postpartum depression and anxiety symptoms were associated with beginning exercise within 12 weeks of giving birth.

HealthDay News — Fezolinetant is safe and effective for moderate-to-severe vasomotor symptoms (VMS), according to a study presented at the annual European Congress of Endocrinology, hosted by the ...

A worse Life’s Essential 8 profile is associated with a 2-fold higher composite risk of developing stroke, dementia, and depression later in life.